The Effect of Donepezil in Radiotherapy-related Cognitive Impairment.

Summary

Purpose: This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the therapeutic effects of donepezil in radiotherapy-related cognitive impairment. Further study details as provided by Sun Yat-sen Memorial Hospital, Sun Yat-sen University / Yameitang. Primary outcome measure: cognitive improvement, which is determined by the difference value of ADAS-cog score before and after the treatment of donepezil.

Timeline

Start

2019-05-01

Primary completion

2022-12-31

Completion

2022-12-31

Drugs

Indications